Physician profile
Daniel E Kenady
NPI 1699724021
$6,344.53
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,087 · 2020: $2,105 · 2021: $27.83 · 2022: $64.93 · 2023: $24.70 · 2024: $34.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.39 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.39 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nx Development Corp. | $6,000.00 | 2019-2020 | |
| Axonics, INC. | $33.84 | 2022-2024 | Axonics |
| Reprise Biomedical, INC. | $27.83 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.97 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.70 | 2023 | Libtayo |
| Portola Pharmaceuticals, LLC | $20.78 | 2019 | |
| Kerecis Limited | $20.18 | 2022 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Bridion |
| Verastem, INC. | $17.99 | 2019 | |
| Janssen Biotech, INC. | $16.80 | 2019 | |
| Genzyme Corporation | $16.60 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.88 | 2019 | |
| Innocoll Pharmaceuticals Limited | $15.85 | 2022 | |
| Puma Biotechnology, INC. | $15.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.97 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $13.54 | 2019 | |
| Melinta Therapeutics, LLC | $12.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.77 | 2019 | |
| Davol INC. | $11.75 | 2022 | |
| Foundation Medicine, INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kenady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.